None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with a minimum pain intensity score greater than 30 mm on a visual analogue scale (VAS, 0 to 100 mm) 2. Diagnosed as the low back pain with medical evidences (e.g. previous radiographic records and independent physical examination) 3. Voluntary participation who clearly understood purpose and characteristics of the clinical trials signed informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients who required the aid of medical devices or attached implantable equipment that could be affected by electromagnetic fields, such as pacemakers or hearing aids 2. Unendurable pain, bone fractures, severe disc herniation, or spinal tumours. 3. Taking drugs such as corticosteroids, anticonvulsants, or anti-inflammatory agents. 4. Pregnancy 5. Patients who experienced any adverse effects due to the physical stimulation therapy 6. Cognitive or mental dysfunction 7. Participated in other clinical trials within the last month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in visual analogue scale (VAS, 100 mm) from the baseline to follow-up period | — |
Secondary
| Measure | Time frame |
|---|---|
| Change of pressure pain threshold (PPT) ;Change of patient's global impression of change (PGIC) ;European Quality of Life-5 Dimensions (EQ-5D) | — |
Countries
Korea, Republic of
Contacts
Cheonan Korean Medicine Hospital of Daejeon University